Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference26 articles.
1. Townsend RR, Mahfoud F, Kandzari DE, et al.; SPYRAL HTN-OFF MED Trial Investigators. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Aug 28 [Epub ahead of print]
2. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281.
3. Esler MD, Krum H, Sobotka PA, et al. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–1909.
4. Turner JR, O’Brien E. Inferences beyond a study design’s grasp: a cautionary case study from the recent renal sympathetic denervation. Therapeutic Innovation & Regulatory Science. 2015;49:86–92.
5. Lee J, Turner JR. Raising the bar in renal sympathetic denervation research and reporting. J Clin Hypertens (Greenwich). 2016;18:89–94.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献